Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Pharmaceutical Investing INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017
Blockchain Investing BLOK Technologies Enters into Letter of Intent to Acquire Mobile Banking and Payment Platform SimpleBlock
Heritage Mining Announces Encouraging Gold Results from New Millennium Drill Program and provides Exploration Update and Strategic Investment
Quimbaya Gold and Denarius Metals Partner to Formalize Artisanal Mining at Tahami Project, Strengthening Long-Term Exploration Strategy
Denarius Metals Announces Binding Letter of Intent with Quimbaya Gold for a 50/50 Joint Venture to Exploit the Tahami Project in the Segovia Gold District of Colombia
